Meredith Goldwasser
SVP, Strategy & Corporate Ops., Prime Medicine, Inc.
Companies
- Prime Medicine, Inc.SVP, Strategy & Corporate Ops. Oct 19, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Prime Medicine, Inc. PRME176,917 shares2$638.7K at $3.61Oct 19, 2022
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2